- Home
- ADXN vs RDHL Comparison
ADXN vs RDHL Comparison
Compare ADXN & RDHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADXN
- RDHL
- Stock Information
- Founded
- ADXN 2002
- RDHL 2009
- Country
- ADXN Switzerland
- RDHL Israel
- Employees
- ADXN N/A
- RDHL N/A
- Industry
- ADXN Biotechnology: Pharmaceutical Preparations
- RDHL Biotechnology: Pharmaceutical Preparations
- Sector
- ADXN Health Care
- RDHL Health Care
- Exchange
- ADXN Nasdaq
- RDHL Nasdaq
- Market Cap
- ADXN 10.1M
- RDHL 4.3M
- IPO Year
- ADXN N/A
- RDHL N/A
- Fundamental
- Price
- ADXN $9.00
- RDHL $1.91
- Analyst Decision
- ADXN Strong Buy
- RDHL
- Analyst Count
- ADXN 1
- RDHL 0
- Target Price
- ADXN $30.00
- RDHL N/A
- AVG Volume (30 Days)
- ADXN 14.3K
- RDHL 15.6K
- Earning Date
- ADXN 08-11-2025
- RDHL 08-28-2025
- Dividend Yield
- ADXN N/A
- RDHL N/A
- EPS Growth
- ADXN N/A
- RDHL N/A
- EPS
- ADXN 0.10
- RDHL N/A
- Revenue
- ADXN $278,508.00
- RDHL $8,042,999.00
- Revenue This Year
- ADXN $86.57
- RDHL $381.91
- Revenue Next Year
- ADXN N/A
- RDHL N/A
- P/E Ratio
- ADXN $0.75
- RDHL N/A
- Revenue Growth
- ADXN N/A
- RDHL 23.17
- 52 Week Low
- ADXN $6.51
- RDHL $1.71
- 52 Week High
- ADXN $13.27
- RDHL $20.28
- Technical
- Relative Strength Index (RSI)
- ADXN 51.86
- RDHL 44.55
- Support Level
- ADXN $8.78
- RDHL $2.00
- Resistance Level
- ADXN $9.89
- RDHL $2.08
- Average True Range (ATR)
- ADXN 0.54
- RDHL 0.10
- MACD
- ADXN -0.05
- RDHL 0.01
- Stochastic Oscillator
- ADXN 35.97
- RDHL 37.05
About ADXN Addex Therapeutics Ltd
Addex Therapeutics Ltd is a clinical-stage biopharmaceutical company. The company is focused on the development and commercialization of an emerging class of novel orally available small-molecule drugs known as allosteric modulators. The company's geographical area of operations includes Switzerland and Europe. The Company operates in one segment, which is the discovery, development, and commercialization of small-molecule pharmaceutical products.
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is dedicated to advancing its development pipeline of clinical-stage therapeutic candidates. It also commercializes GI-related products in the U.S., including Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). Currently, the company's pipeline consists of five therapeutic candidates: Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, the majority of which are in clinical development.